Stock Spotlight Archives - Page 173 of 383

WednesdayJul 21, 2021 1:52 pm

QualityStocksNewsBreaks – BAND Royalty Tapping ‘Secret Hidden World of Investing’

BAND Royalty, an enterprising music technology company, has emerged as a revolutionary new player in the non-fungible token (“NFT”) market. The company has applied its experience in music industry investments to the digital art collectibles arena in order to create a new type of best-of-both-worlds product. The product combines NFT art with a potential DeFi project that allows people to share in music royalties. BAND Royalty’s first series of 3,000 NFTs made available for sale to the public on May 15 includes royalties from music catalog selections featuring artists such as Justin Timberlake, Jay-Z, Beyonce and Timbaland. According to a…

WednesdayJul 21, 2021 1:38 pm

QualityStocksNewsBreaks– Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) Advocates for Temperature-Fighting Cannabis to Beat Record Heat

Chalice Brands (CSE: CHAL) (OTCQB: CHALF), a consumer-driven cannabis company in the medicinal and recreational marijuana market segments, is building a strong presence in Oregon. This presence allows interested Oregonians to test the cannabis cooling theory captured in a Chalice magazine article titled “Cannabis Is Cool.” The theory states that: “Cannabinoids, compounds found in cannabis, can interact with the hypothalamus and endocannabinoid system and subsequently impact temperature regulation while also occupying the vanilloid receptor family (TRPA-1, TRPM8, etc.). . . . Thanks to our interest in cannabis, we know the vanilloid receptors alter our perception of heat and pain and,…

WednesdayJul 21, 2021 1:26 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Moving Psychedelic Therapeutics Field Forward Through Partnership

Cybin (NEO: CYBN) (OTCQB: CLXPF), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, is sponsoring research to see if psychedelic medicine, when used with EMBARK’s supportive therapy, can help clinicians recover from COVID-related distress. The recently launched EMBARK is a groundbreaking psychotherapy model that integrates leading clinical approaches to promote supportive healing with psychedelic medicine. Cybin has co-sponsored the study — which will be led by Dr. Anthony Back, a recognized leader in the fields of palliative care and oncology — in a strategic collaboration with the University of Washington. The study will examine treating…

WednesdayJul 21, 2021 11:42 am

QualityStocksNewsBreaks – Hero Technologies Inc.’s (HENC) Business Strategy Reaffirmed as Trend Moves Toward Greenhouse Cultivation

Hero Technologies (OTC: HENC) has a majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation system that provides optimal conditions in greenhouses to enhance photosynthesis and produce large flowering plants. Thus, the trend toward greenhouse cultivation is welcome news for HENC. A recent article reads, “According to a recent five-year study of the cannabis industry, greenhouse production is a leading choice for cannabis cultivation companies (https://ibn.fm/fh11k). The report, published by ‘Cannabis Business Times,’ reaffirms the business strategy of Hero Technologies.” It noted that greenhouse production continues to be the top tool for reducing the initial and operational…

TuesdayJul 20, 2021 12:33 pm

QualityStocksNewsBreaks – Why Lexaria Bioscience Corp. (NASDAQ: LEXX) Is ‘One to Watch’

Lexaria Bioscience Corp. (NASDAQ: LEXX) is the global innovator behind the patented DehydraTECH(TM) technology. DehydraTECH increases the effectiveness of lipophilic (fat-soluble) drugs and active ingredients and improves the way active pharmaceutical ingredients enter the bloodstream. It speeds up delivery, increases bioavailability, increases brain absorption, improves drug potency, reduces drug administration cost and masks unwanted taste. A recent article reads, “Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats. The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription…

TuesdayJul 20, 2021 11:55 am

QualityStocksNewsBreaks– BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Responds to Soaring Consumer Demand for TRACE Products

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, inked two new distribution deals, significantly expanding its North American footprint for its TRACE lineup of alkaline and mineral-infused water products. The deals — with Koyo Foods, one of the largest health food distributors in Eastern Canada, and Benefit Brand Management, a leading wholesaler of natural products in the United States — grew BevCanna’s initial distribution network and fueled demand for the products. “In response to consumer demand for take-home and value-priced options, BevCanna is launching new TRACE multi-packs in national retailers…

FridayJul 16, 2021 1:48 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Stands Distinct in Precision Medicine

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, is leveraging its unique, historical database of the drug responses of over 150,000 patient tumors to build data-driven predictive models of tumor drug response. These models will provide actionable insights critical to both new drug development and individualizing patient treatment. “While others must wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine,” a recent article reads. “Predictive Oncology presently has the clinical information, including tumor drug response data and…

FridayJul 16, 2021 1:17 pm

QualityStocksNewsBreaks – Infobird Software Co. Ltd.’s (NASDAQ: IFBD) SaaS Solutions Gaining Recognition from Reputable Retail Enterprises

Infobird (NASDAQ: IFBD), a business-to-business (“B2B”) artificial intelligence (“AI”) solutions company, recently announced its platform would provide Zu Li Jian, a pioneer in the production of footwear for the elderly in China, with cloud-native, autonomous and controllable source code resources to create flexible customization and expansion for Zu Li Jian’s own e-shopping platform. Through IFBD’s upgrade, Zu Li Jian’s customer service platform will now boast high stability, high concurrency and high expansion capability, making it responsive to future needs and business peaks. “The announcement follows on the heels of a similar intelligent B2B collaboration that will deliver enhanced customer service…

FridayJul 16, 2021 12:25 pm

QualityStocksNewsBreaks – Hero Technologies Inc. (HENC) Further Diversifies, Executes Growth Strategy Through MassCannabis

Hero Technologies (OTC: HENC) recently moved to capitalize on the potential of the Massachusetts market by forming a subsidiary, MassCannabis, to seek property or land acquisition opportunities in the state and potentially initiate dispensary projects. “Last year, the nonmedical cannabis market in Massachusetts hit a significant milestone: $1 billion in sales since the state voted to legalize the substance — this even though the state was one of only a handful that closed cannabis shops for a period of time because of COVID-19,” reads a recent article. According to Hero Technologies CEO Gina Serkasevich, “In forming our new MassCannabis subsidiary,…

FridayJul 16, 2021 11:48 am

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Brings Powerful Capabilities to Modern Clinical Trials

RYAH Group (CSE: RYAH), a health care analytics and technology company, has created IoT dose-measuring devices backed by powerful data analytics. These provide next-generation capabilities that allow for more control of variables within a clinical setting, which is especially significant in modern cannabis clinical trials. While historical emphasis has largely been centered on potential harmful effects, today’s research teams are exploring the use of cannabis to address a wide range of chronic conditions, while it holds significant potential for pain relief. The future of cannabis study with the addition of dose-measuring devises looks promising, and RYAH is front-and-center on the…

Site Search

Company Search

Category: Stock Spotlight